Gynecologic Oncology

Scope & Guideline

Transforming Knowledge into Practice in Gynecologic Oncology

Introduction

Delve into the academic richness of Gynecologic Oncology with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN0090-8258
PublisherACADEMIC PRESS INC ELSEVIER SCIENCE
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 1972 to 2024
AbbreviationGYNECOL ONCOL / Gynecol. Oncol.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address525 B ST, STE 1900, SAN DIEGO, CA 92101-4495

Aims and Scopes

The journal "Gynecologic Oncology" aims to advance the understanding and treatment of gynecologic cancers through rigorous research and clinical studies. It serves as a platform for disseminating innovative findings, treatment methodologies, and insights into the epidemiology, pathology, and molecular biology of gynecologic malignancies.
  1. Clinical Research and Trials:
    Focus on clinical trials evaluating new treatment modalities, including chemotherapy, immunotherapy, and targeted therapies for gynecologic cancers.
  2. Molecular and Genetic Insights:
    Investigation into the molecular and genetic factors that influence the pathogenesis of gynecologic cancers, including studies on biomarkers and genetic predispositions.
  3. Quality of Life and Patient Outcomes:
    Research on the impact of gynecologic cancer treatments on quality of life, survivorship, and the psychosocial aspects of care.
  4. Health Disparities and Access to Care:
    Exploration of disparities in incidence, treatment, and outcomes of gynecologic cancers across different populations, with a focus on improving access to care.
  5. Surgical Techniques and Innovations:
    Studies on advancements in surgical techniques, including minimally invasive approaches and their impact on patient recovery and outcomes.
  6. Epidemiology and Prevention:
    Research addressing epidemiological trends, risk factors, and preventive strategies for gynecologic cancers.
The journal is increasingly focusing on emerging themes that reflect the evolving landscape of gynecologic oncology, with particular emphasis on personalized medicine and health equity.
  1. Personalized and Precision Medicine:
    There is a growing emphasis on personalized treatment approaches based on genetic and molecular profiling, aiming to tailor therapies to individual patient needs.
  2. Immunotherapy and Targeted Therapies:
    Research on immunotherapy and targeted agents is trending, reflecting a shift in treatment paradigms for gynecologic malignancies.
  3. Health Equity and Access:
    Emerging studies focus on health equity, exploring barriers to care and treatment disparities among different racial and ethnic groups.
  4. Patient-Centered Care Models:
    A trend towards research that evaluates patient-reported outcomes and satisfaction, emphasizing the importance of patient perspectives in treatment planning.
  5. Telehealth and Remote Monitoring:
    Increased focus on the role of telehealth and remote monitoring in providing care during and post-COVID-19, highlighting innovative adaptations in patient management.
  6. Long-Term Survivorship and Quality of Life:
    Research on long-term survivorship issues and quality of life after treatment is gaining traction, with studies aimed at understanding the holistic needs of cancer survivors.

Declining or Waning

While the journal continues to cover a broad array of topics related to gynecologic oncology, certain themes appear to be declining in prominence based on recent publication trends.
  1. Traditional Chemotherapy Focus:
    There is a noticeable shift away from studies solely focusing on traditional chemotherapy regimens, as newer targeted therapies and immunotherapies gain prominence.
  2. Basic Science Research:
    There is a decline in purely basic science research studies, with a stronger emphasis now on translational and clinical research that directly impacts patient care.
  3. Single-Institution Studies:
    The prevalence of single-institution studies is decreasing, as there is a growing trend toward multicenter studies that provide broader, more generalizable results.
  4. General Surgical Techniques:
    Research on standard surgical techniques without specific innovations or improvements is becoming less common as the focus shifts toward novel surgical methods and technologies.

Similar Journals

World Journal of Clinical Oncology

Fostering Collaboration in the Fight Against Cancer
Publisher: BAISHIDENG PUBLISHING GROUP INCISSN: 2218-4333Frequency: 12 issues/year

World Journal of Clinical Oncology, published by BAISHIDENG PUBLISHING GROUP INC, stands as a vital resource in the realm of oncology, providing a dedicated platform for the dissemination of cutting-edge research and clinical advancements. With an ISSN of 2218-4333, this journal facilitates a comprehensive exploration of modern oncology challenges and breakthroughs, targeting researchers, healthcare professionals, and students alike. Although it operates under the traditional subscription model, the impactful nature of its content is reflected in its notable ranking of 60 out of 334 in the category of Medicine _ Oncology, placing it in the 82nd percentile among peer publications. Covering significant topics in clinical oncology from 2014 to 2018, the journal has been instrumental in addressing evolving oncology practices and patient care innovations. By publishing high-quality studies, it remains an essential tool for advancing knowledge and fostering collaboration within the global oncology community.

BREAST CANCER RESEARCH AND TREATMENT

Exploring New Frontiers in Oncology
Publisher: SPRINGERISSN: 0167-6806Frequency: 18 issues/year

Breast Cancer Research and Treatment, published by Springer, stands as a pivotal journal within the domains of Cancer Research and Oncology, exemplified by its impressive Q2 and Q1 quartile rankings, respectively, in the 2023 category rankings. Since its inception in 1981, this journal has provided a vital platform for disseminating cutting-edge research focused on all aspects of breast cancer, ranging from molecular biology to treatment strategies. With an ISSN of 0167-6806 and E-ISSN of 1573-7217, it captures a broad audience of researchers, clinicians, and students dedicated to improving patient outcomes. The journal emphasizes high-quality, peer-reviewed studies that pave the way for advancements in therapy and direct novel insights into oncological practices. By maintaining a strong ranking in Scopus with percentile placements of 74th in Oncology and 61st in Cancer Research, Brest Cancer Research and Treatment continues to foster innovation and collaboration in the fight against breast cancer.

PEDIATRIC HEMATOLOGY AND ONCOLOGY

Uniting researchers and practitioners for a healthier future.
Publisher: TAYLOR & FRANCIS INCISSN: 0888-0018Frequency: 8 issues/year

Pediatric Hematology and Oncology, published by Taylor & Francis Inc, serves as a vital platform dedicated to the fields of hematology, oncology, and pediatrics, providing a comprehensive avenue for the dissemination of scholarly research and clinical advancements. With an ISSN of 0888-0018 and an E-ISSN of 1521-0669, this journal has successfully converged its expertise over the years from 1984 to 2024. Ranked in the Q3 category for Hematology and Oncology, alongside a Q2 ranking in Pediatrics, Perinatology, and Child Health (2023), it engages a diverse readership comprising researchers, healthcare professionals, and students eager to explore groundbreaking studies in child health and treatment methodologies. While it currently does not offer Open Access options, the journal is widely cited and recognized, particularly in its specialized fields, fostering a rich environment for dialogue and innovation in the management of pediatric hematological and oncological disorders. The journal is based in the United Kingdom at 530 Walnut Street, Ste 850, Philadelphia, PA 19106, making it an essential resource for those pursuing excellence in pediatric medical research.

Indian Journal of Gynecologic Oncology

Exploring innovations in gynecologic cancer care.
Publisher: SPRINGER INDIAISSN: 2363-8397Frequency: 1 issue/year

Indian Journal of Gynecologic Oncology, published by SPRINGER INDIA, is a distinguished platform dedicated to the rigorous dissemination of research and advancements in the fields of gynecologic oncology. With an ISSN of 2363-8397 and E-ISSN of 2363-8400, the journal aims to bridge the gap between clinical practice and research in obstetrics and gynecology, while also addressing pivotal issues in oncology. Operating from its headquarters in New Delhi, India, the journal has been active since 2016 and is recognized within the academic community, achieving a Category Quartile of Q3 in Obstetrics and Gynecology and Q4 in Oncology as of 2023. Although currently not an open-access journal, it offers extensive access options for subscribing institutions and professionals. With its commitment to high-quality peer-reviewed content, the journal serves as a vital resource for researchers, clinicians, and students dedicated to advancing knowledge and improving patient outcomes in gynecologic cancers.

Journal of Thoracic Oncology

Empowering Innovation in Thoracic Oncology
Publisher: ELSEVIER SCIENCE INCISSN: 1556-0864Frequency: 12 issues/year

Journal of Thoracic Oncology, published by Elsevier Science Inc, is a premier scholarly outlet dedicated to advancing the field of thoracic oncology. With an impressive impact factor and consistently rated in the Q1 quartile across several pertinent categories such as Medicine, Oncology, and Pulmonary and Respiratory Medicine, this journal stands at the forefront of research dissemination. Covering a broad scope that includes innovative therapeutic approaches, clinical trials, and the molecular underpinnings of thoracic malignancies, the journal serves as a vital resource for researchers, healthcare professionals, and students seeking to enhance their understanding of thoracic cancer and its treatment. With publication dates converging from 2006 to 2024, the Journal of Thoracic Oncology fosters a collaborative scholarly community by providing a platform for high-quality research while ensuring accessibility through traditional publication formats. Positioned in the heart of New York City, this journal not only reflects the cutting-edge advancements in oncology but also plays a pivotal role in shaping the future of thoracic cancer care.

BRITISH JOURNAL OF CANCER

Leading the Charge in Cancer Research Excellence.
Publisher: SPRINGERNATUREISSN: 0007-0920Frequency: 24 issues/year

The British Journal of Cancer, published by SpringerNature, stands as a preeminent resource in the fields of Cancer Research and Oncology, with a distinguished history of publication dating back to 1947. With its Q1 rank in both categories for 2023, this journal is among the top-tier publications, offering cutting-edge research and insights into the biology, etiology, and treatment of cancer. The journal’s rigorous peer-review process ensures that readers are presented with high-quality studies that contribute to the advancement of cancer knowledge and clinical practice. Operating from the United Kingdom, it has garnered a notable impact factor and ranks impressively within Scopus, making it an essential publication for researchers, healthcare professionals, and students who are dedicated to understanding cancer's complexities. Access to the journal's articles is available in traditional formats, providing a versatile platform for disseminating pivotal research. As we move towards a future where cancer treatment and prevention remain crucial, the British Journal of Cancer continues to play a vital role in shaping the dialogue and discoveries within the oncology community.

Journal of the Turkish-German Gynecological Association

Advancing Women's Health Through Cross-Cultural Collaboration
Publisher: GALENOS PUBL HOUSEISSN: 1309-0399Frequency: 4 issues/year

The Journal of the Turkish-German Gynecological Association, published by GALENOS PUBL HOUSE, stands as a significant contribution to the field of obstetrics and gynecology, fostering a vital dialogue between Turkish and German medical communities since its establishment. This peer-reviewed, Open Access journal, which has been accessible since 2000, provides a platform for the dissemination of cutting-edge research, clinical practices, and reviews that are pivotal for advancing women's health. With a current impact factor correlation reflecting its status within the Q3 category in the obstetrics and gynecology domain, the journal is ranked #108 out of 209 in Scopus, placing it in the 48th percentile for its field. Covering a broad range of topics from innovative treatment methods to emerging technologies in gynecology, this journal is dedicated to enriching the academic landscape and providing healthcare professionals, researchers, and students with valuable insights and knowledge essential for improving patient outcomes. The journal’s headquarters in Turkey underscores its commitment to enriching local and international discourse in women's health.

Taiwanese Journal of Obstetrics & Gynecology

Fostering Excellence in Obstetrics and Gynecology Scholarship
Publisher: ELSEVIER TAIWANISSN: 1028-4559Frequency: 4 issues/year

Taiwanese Journal of Obstetrics & Gynecology, published by Elsevier Taiwan, stands as a leading platform in the field of obstetrics and gynecology, fostering academic discourse and innovative research since its inception in 2004. With an impact factor that places it in the Q2 category of its field, it ranks #84 out of 209 journals in Obstetrics and Gynecology according to Scopus, indicating a significant reputation within the medical community. This open access journal ensures wide dissemination of research findings, allowing professionals, researchers, and students alike to stay updated with the latest advancements and practices. The journal's focus on publishing high-quality, peer-reviewed articles covers a broad range of topics within the field, making it an essential resource for those interested in women's health issues, clinical practices, and medical advancements in Taiwan and beyond. With its commitment to excellence, the Taiwanese Journal of Obstetrics & Gynecology invites contributions that enhance the understanding and management of obstetric and gynecological care.

Cancers

Connecting researchers for a cancer-free future.
Publisher: MDPIISSN: Frequency: 24 issues/year

Cancers is a leading peer-reviewed journal published by MDPI, dedicated to advancing the field of oncology and cancer research. Established in 2009 and based in Switzerland, this Open Access journal provides a platform for the rapid dissemination of high-quality research findings, reviews, and clinical studies related to all aspects of cancer biology and treatment. With an impressive impact factor and recognized as Q1 in Oncology and Q2 in Cancer Research for 2023, Cancers strives to foster a collaborative environment among researchers, healthcare professionals, and students seeking to deepen their knowledge and understanding of cancer. The journal’s commitment to accessibility and its broad scope make it an invaluable resource for anyone passionate about combating cancer and improving patient outcomes. For more information and to access its diverse publications, visit the journal’s website.

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Elevating the standard of care with peer-reviewed discoveries.
Publisher: ELSEVIER SCIENCE INCISSN: 1078-1439Frequency: 12 issues/year

Urologic Oncology - Seminars and Original Investigations is a premier journal published by Elsevier Science Inc, dedicated to advancing the field of urologic oncology through high-quality, peer-reviewed research and insightful scholarly discussions. With an ISSN of 1078-1439 and an E-ISSN of 1873-2496, this journal has established itself as a vital resource for professionals, researchers, and students alike since its inception in 1995. Currently holding a Q2 ranking in Oncology and a prestigious Q1 in Urology for 2023, it ranks 28th out of 120 in Urology and 177th out of 404 in Oncology within Scopus, underscoring its relevance and impact in these critical fields. While the journal operates under a subscription model, it continues to deliver compelling and transformative research aimed at enhancing patient outcomes in urologic oncology. With a focus on innovative therapies, diagnostic advancements, and clinical trials, the journal contributes significantly to ongoing dialogue and development in urologic health care.